Duke & Deerfield Announce Four Points Innovation

Deerfield Management commits up to $130 million to accelerate drug discovery at Duke through a newly launched company

Positive Clinical Trials & $10.7M Investment for Polarean Paves Way for NDA

Medical Imaging Device company hoping to submit new drug application (NDA) later this year

Viela Bio Announces U.S. FDA Approval of UPLIZNA™

UPLIZNA™ is the first and only B cell depleter approved for the treatment of NMOSD in adults who are anti-aquaporin-4 antibody positive

Grid Therapeutics Announces 1st Patient in Phase 1 Study

GT103 is a therapeutic antibody derived from single B cells of cancer patients

From Campus to Commercialization: Celebrating Duke’s Novel Innovations

From drug-resistant AI to AR brain models–Duke puts its innovative spirit on display again at the 3rd Annual Invented at Duke

3D-Printing Gives Medical Teams COVID Protection

COVID-19 Engineering Response Team tackles powered, air-purifying respirator (PAPR)

NASA Climbs Aboard with Support for Robot Project

Robots that insert IVs into patients’ arms already exist, this one is designed for use by someone without clinical training

FDA clearance for hernia mesh product approved for Deep Blue

Deep Blue has been approved to start selling their hernia mech technology after receiving FDA approval

Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial

PBCAR269A targets BCMA for the treatment of relapsed/refractory multiple myeloma